GlenmarkPh n4.5%210802S 4N4B

General Announcement::Glenmark Pharmaceutical launches the biosimilar of Adalimumab in India

Original SGX announcement

Read the archived filing

Membership includes the on-site filing reader and available attachments.

SGD 5 / month
Billed automatically. Cancel any time.

Sign in to subscribe
What membership includes
  • Full recorded dividend history
  • Archived SGX filing details and available attachments
  • Ad-free browsing